award

Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies

  • Award Number: R01CA268518

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)